Your library for CRO & clinical trials

Learn more about Lindus Health from our blog page. Our posts cover an array of topics from clinical developments to diversity.

General

End-to-End Innovation: How Technology is Transforming Every Step of the Clinical Trial Value Stream

Michael Young, Co-CEO of Lindus Health, outlines how digital tools are enabling faster insights, better patient experiences, and smarter outcomes from protocol design to patient follow-up.

Why Clinical Evidence Matters In Fertility Tech – And Beyond

The digital transformation of the fertility space has brought us everything from period tracking apps to FDA-cleared digital contraceptives. Yet these tools are often grouped together under broad categories that obscure critical differences in their purpose and effectiveness.

Clinically Proven, Commercially Trusted: Rethinking Validation for OTC Brands

Consumer health is a $6.3 trillion mainstream market with consumers prioritizing solutions that help them feel and look better and live longer. Yet in this crowded, fast-moving space, one principle stands above all others: trust is the foundation of strong consumer health brands.

Designing Ovarian Cancer Diagnostics: Navigating Hormonal, Cultural, and Clinical Barriers to Early Detection

Ovarian cancer remains one of the most lethal gynecological cancers, largely because diagnosis often comes too late. Around 70% of cases are detected at an advanced stage, with approximately 300,000 new cases each year.

August 27, 2025

Mins

Latest stories

Lindus Staff

Author

Medical Device Marketing EU vs US: Why Your Launch Strategy Needs a Continental Divide

For medical device companies looking to grow globally, expanding into both the US and EU often feels like the logical next step. But many teams quickly learn that what works in one region doesn’t always translate to the other. Despite some similarities, the US and EU operate within different regulatory and commercial frameworks.

July 4, 2025

Lindus Staff

Author

GLP-1 Agents: Expanding Therapeutic Horizons Beyond Diabetes and Weight Management

GLP-1 receptor agonists are quickly becoming versatile treatments with proven effectiveness in cardiovascular disease, chronic kidney disease, sleep apnea, and Alzheimer’s Disease. Early clinical data suggest they may also help in neurodegeneration, osteoarthritis, and other inflammatory conditions, making this drug class a potential game-changer in metabolic medicine, where specialized CRO support is critical for navigating complex clinical development.

July 1, 2025